When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Stomach cancer - Wikipedia

   en.wikipedia.org/wiki/Stomach_cancer

   Among men, 683 754 cases were diagnosed, accounting for 7.2% of all cancer cases, and among women, stomach cancer was diagnosed in 349 947 cases, accounting for 4.1% of all cancer cases. [96] In 2012, stomach cancer was the fifth most-common cancer with 952,000 cases diagnosed. [16] It is more common both in men and in developing countries.

3. Obesity and cancer - Wikipedia

   en.wikipedia.org/wiki/Obesity_and_cancer

   Obesity has been associated with an increased risk of esophageal cancer, pancreatic cancer, colorectal cancer, breast cancer (among postmenopausal women), endometrial cancer, kidney cancer, thyroid cancer, liver cancer and gallbladder cancer. [2] Obesity may also lead to increased cancer-related mortality. [1] Obesity has also been described as ...

4. Diet and cancer - Wikipedia

   en.wikipedia.org/wiki/Diet_and_cancer

   Betel nut chewing causes oral cancer. [9] Stomach cancer is more common in Japan due to its high-salt diet. [9] [11] Dietary recommendations for cancer prevention typically include weight management and eating a healthy diet, consisting mainly of "vegetables, fruit, whole grains and fish, and a reduced intake of red meat, animal fat, and ...

5. Woman, 23, had a 'burning sensation' in her stomach. It was ...

   www.aol.com/news/woman-23-had-burning-sensation...

   Sydney Towle, then 23, had a bump in her stomach that she thought was a hernia. Then she felt burning. She had bile duct cancer, rare for her age.

6. Unexplained weight loss can be one of the first signs of ...

   www.aol.com/lifestyle/unexplained-weight-loss...

   Experts say that recent, unexplained weight loss is a "well-known phenomenon" associated with cancer. But other health conditions can cause weight loss as well.

7. Weight-loss drugs like Ozempic, Wegovy linked to severe ... - AOL

   www.aol.com/news/woman-sues-makers-ozempic...

   Sodhi and his colleagues examined health insurance claims to find people who had obesity, but not diabetes, and took GLP-1 agonists — including semaglutide, the active ingredient in Ozempic and ...